The contract research organization will launch an expanded ISO 18562 gas pathway testing program and ISO 10993-18 particulate ...
Medical Device Network on MSN
NAMSA acquires Labcorp’s medical device testing assets
The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.
DUBLIN, April 13, 2021 /PRNewswire/ -- The "Medical Device Testing Market with COVID-19 Impact, By Services (Testing, Inspection, Certification), Sourcing, Technology ...
As data-driven innovation profoundly changes every industry, the healthcare sector is also affected. Digital twins – virtual copies of physical devices – are essentially changing the ...
Eurofins Medical Device Services North America, part of a global network of over 20 medical device testing laboratories and a leading medical device solutions partner, recently launcheda GMPPFAS ...
Asia has become a magnet for medical device OEMs seeking a slice of the region's exploding economy. As the demand for testing and sterilization grows, the industry there is looking increasingly for ...
Medical device manufacturers use cytotoxicity testing to help prove that devices that come into contact with the human body are biocompatible. Testing results are critical for gaining market access, ...
TOLEDO, Ohio--(BUSINESS WIRE)--NAMSA, the world’s only 100% medical device-focused Contract Research Organization (CRO) providing full continuum development solutions, announced today that the U.S.
Filter testing is used to evaluate a filter's ability to separate microorganisms of various sizes and helps manufacturers determine membrane pore size. This test is also an excellent batch release ...
LAUREL, N.J. - InTest Corporation (NYSE American:INTT), a small-cap technology company with a market capitalization of $94.11 million, has secured a $3.7 million follow-on order from an existing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback